机构:[1]The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.[2]Department of Oncology, The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China.[3]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.[4]Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.深圳市中医院深圳医学信息中心[5]Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangdong Basic and Applied
Basic Research Foundation (No. 2020A1515110877), Innovation
Team and Talents Cultivation Program of National
Administration of Traditional Chinese Medicine (No:
ZYYCXTD-C-202208), Double First-Class and High-level
University Discipline Collaborative Innovation Team Project of
Guangzhou University of Chinese Medicine (No. 2021xk23).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学
第一作者:
第一作者机构:[1]The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Gao Tianqi,Li Mengping,Wu Dailin,et al.Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis[J].Frontiers in pharmacology.2023,14:1201401.doi:10.3389/fphar.2023.1201401.
APA:
Gao Tianqi,Li Mengping,Wu Dailin,Xiao Ni,Huang Dan...&Yu Yang.(2023).Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis.Frontiers in pharmacology,14,
MLA:
Gao Tianqi,et al."Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis".Frontiers in pharmacology 14.(2023):1201401